Related Articles
Transcriptomic signature predicts the distant relapse in patients with ER+ breast cancer treated with tamoxifen for five years
A population-based gene signature is predictive of breast cancer survival and chemoresponse
Development of a nine‑lncRNA signature as a novel prognostic marker of estrogen receptor‑negative breast cancer
BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survival
A pilot study of the effects of short-term tamoxifen therapy on Ki-67 labelling index in women with primary breast cancer.